Literature DB >> 2420734

Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.

M Wiranowska-Stewart, J W Hadden.   

Abstract

Two purine immunoenhancing drugs, isoprinosine and NPT 15392, were evaluated as inducers of IL-2 or enhancers of IL-2 induction by phytohemagglutinin (PHA). Both drugs were found to have significant enhancing activity on PHA induction of IL-2 by human lymphocytes over a wide range of concentrations. Alone they were unable to consistently induce IL-2 activity. NPT 15392 was able to enhance PHA-induced IL-2 production at 10-100 times lower concentrations than isoprinosine. The actions of these compounds to enhance IL-2 production may explain their effects on PHA-induced lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420734     DOI: 10.1016/0192-0561(86)90074-3

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  5 in total

Review 1.  New approaches to the treatment of rheumatoid arthritis.

Authors:  P A Miescher; Y P Huang; R H Zubler
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients.

Authors:  J Richner; E P Ambinder; K Hoffmann; E J Feuer; G Bekesi
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 3.  Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.

Authors:  Jiri Sliva; Chrysoula N Pantzartzi; Martin Votava
Journal:  Adv Ther       Date:  2019-06-05       Impact factor: 3.845

4.  Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression.

Authors:  Michael T McCarthy; Da Lin; Tomoyoshi Soga; Julie Adam; Christopher A O'Callaghan
Journal:  Eur J Immunol       Date:  2019-09-12       Impact factor: 5.532

Review 5.  Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.

Authors:  Jiří Beran; Marián Špajdel; Jiří Slíva
Journal:  Viruses       Date:  2021-11-09       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.